(2026). Derivation and external validation of a prognostic nomogram for human epidermal growth factor receptor 2 negative early young breast cancer in women. Discover Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Derivation and External Validation of a Prognostic Nomogram for Human Epidermal Growth Factor Receptor 2 Negative Early Young Breast Cancer in Women."
Discover Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Derivation and External Validation of a Prognostic Nomogram for Human Epidermal Growth Factor Receptor 2 Negative Early Young Breast Cancer in Women."
Discover Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.